| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $133.6M | +12.2% |
| SG&A Expense | $33.8M | +3.7% |
| Operating Income | -$116.2M | -487.1% |
| Pre-tax Income | -$103.2M | -642.3% |
| Income Tax | -$9.4M | -161.9% |
| Net Income | -$93.8M | -222.9% |
| EPS (Basic) | -$2.23 | -223.2% |
| EPS (Diluted) | -$2.23 | -223.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.3M | -30.2% |
| Short-term Investments | $112.4M | -39.1% |
| Current Assets | $243.7M | -31.2% |
| Total Assets | $253.9M | -30.3% |
| Current Liabilities | $39.1M | -50.3% |
| Total Liabilities | $41.8M | -50.5% |
| Stockholders' Equity | $212.1M | -24.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$127.2M | — |
| Capital Expenditures | $1.9M | +221.9% |
| Investing Cash Flow | $78.0M | +144.4% |
| Financing Cash Flow | $842K | -4.3% |
| Free Cash Flow | -$129.1M | — |